Double Bond Pharmaceutical International AB Logo

Double Bond Pharmaceutical International AB

DBP B | SPGR

Overview

Corporate Details

ISIN(s):
SE0007185517 (+1 more)
LEI:
254900U1MWE2YSPREX74
Country:
Sweden
Address:
Virdings Alle 32B, 754 50 Uppsala
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Double Bond Pharmaceutical International AB is a pharmaceutical company specializing in the redevelopment of established drugs to improve their safety and efficacy. The company's strategy centers on applying its proprietary drug delivery technologies to create new formulations of proven medications. Its key platforms include BeloGal®, a biomimetic encapsulation system that enables targeted delivery of active ingredients to specific organs, and an innovative hydrogel for localized treatment. This approach aims to enhance therapeutic effects while minimizing systemic toxicity. The company's pipeline focuses on areas with significant unmet medical needs, such as oncology and infectious diseases. Lead candidates include SI-053 for glioblastoma (brain cancer), SA-033 for liver cancer, and Belopenem for pneumonia.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Double Bond Pharmaceutical International AB. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Double Bond Pharmaceutical International AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Double Bond Pharmaceutical International AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Univo Pharmaceuticals Ltd. Logo
Vertically integrated biopharma firm developing medical cannabis treatments with a focus on CNS.
Israel UNVO-M
Valbiotis Logo
Develops clinically tested, plant-based supplements for metabolic & cardiovascular health.
France ALVAL
Valneva SE Logo
Specialty vaccine developer for travelers and infectious diseases like chikungunya.
France VLA
VENTURE LIFE GROUP PLC Logo
Develops and distributes consumer self-care products for the ageing population worldwide.
United Kingdom VLG
Vetoquinol SA Logo
Develops and distributes veterinary drugs and products for livestock and companion animals globally.
France VETO
Vifor Pharma AG Logo
Develops iron-based pharmaceuticals for iron deficiency, nephrology, and rare diseases.
Switzerland VIFN
Virbac Logo
A pharmaceutical company developing animal health solutions for vets, farmers, and pet owners worldwide.
France FR000
ViroGates A/S Logo
Develops suPAR diagnostic tests for inflammation risk assessment in acute care and longevity.
Denmark VIRO
Vistin Pharma Logo
A leading global producer of Metformin API for the international pharmaceutical industry.
Norway VISTN
Vita 34 AG Logo
A cell bank storing umbilical cord stem cells as biological insurance for families' future health.
Germany V3V